Sfoglia per Autore
Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasia.
2004 MANDREOLI M; FINELLI C; LOPEZ A; ASCANI S; VIANELLI N; BACCARANI M.; SANTORO A.
Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome.
2006 Follo MY; Bosi C; Finelli C; Fiume R; Faenza I; Ramazzotti G; Gaboardi GC; Manzoli L; Cocco L.
PI-PLCbeta1 Expression in Patients with High-Risk Myelodysplastic Syndromes Is Affected by Azacitidine Treatment.
2007 Carlo Finelli; Matilde Y. Follo; Costanza Bosi; Sara Mongiorgi; Cristina Clissa; Giovanni Martinelli; Michele Baccarani; Alberto M. Martelli; Lucio Cocco
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation
2007 Follo, Matilde Y.; Mongiorgi, Sara; Bosi, Costanza; Cappellini, Alessandra; Finelli, Carlo; Chiarini, Francesca; Papa, Veronica; Libra, Massimo; Martinelli, Giovanni; Cocco, Lucio; Martelli, Alberto M.
Paraplegia due to a paravertebral extramedullary haemopoiesis in a patient with polycythaemia vera.
2007 Piccaluga PP; Finelli C; Vigna E; Agostinelli C; Bacci F; Paolini S; Papayannidis C; Laterza C; Martinelli G; Pileri SA; Baccarani M.
PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes
2008 Follo MY; Finelli C; Bosi C; Martinelli G; Mongiorgi S; Baccarani M; Manzoli L; Blalock WL; Martelli AM; Cocco L
PKR is activated in MDS patients and its subcellular localization depends on disease severity.
2008 Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Martinelli G; Blalock WL; Cocco L; Martelli AM.
Identification of Novel Cryptic Chromosomal Abnormalities in Primary Myelofibrosis by Single-Nucleotide Polymorphism Oligonucleotide Microarray.
2009 Visani G.; Isidori A.; Sapienza MR.; Righi S.; Laginestra A.; Agostinelli C.; Sabattini E.; De Nictolis M.; Valentini M.; Donati M.; Emiliani R.; Gazzola A.; Mannu C.; Rossi M.; Alesiani F.; Martinelli G.; Iacobucci I.; Paolini S.; Ascani S.; Finelli C.; Vianelli N.; Pileri SA.; Piccaluga PP.
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients.
2009 Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele Baccarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco
Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.
2009 Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martelli AM; Cocco L.
Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes.
2009 17. Voso MT; Santini V; Finelli C; Musto P; Pogliani E; Angelucci E; Fioritoni G; Alimena G; Maurillo L; Cortelezzi A; Buccisano F; Gobbi M; Borin L; Di Tucci A; Zini G; Petti MC; Martinelli G; Fabiani E; Fazi P; Vignetti M; Piciocchi A; Liso V; Amadori S; Leone G.
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS.
2009 Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Testoni N; Chiarini F; Ramazzotti G; Baccarani M; Martelli AM; Manzoli L; Martinelli G; Cocco L
Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study
2010 Carla Filì; Carlo Finelli; Marco Gobbi; Giovanni Martinelli; Ilaria Iacobucci; Emanuela Ottaviani; Lucio Cocco; Matilde Y. Follo; Anna Candoni; Erika Simeone; Maurizio Miglino; Francesco Lauria; Monica Bocchia; Marzia Defina; Cristina Clissa; Francesco Lanza; Antonio Curti; Stefania Paolini; Pier Angelo Spedini; Cristina Skert; Cesare Bergonzi; Michele Malagola; Annalisa Peli; Alessandro Turra; Federica Cattina; Chiara Colombi; Domenico Russo
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study.
2010 Gattermann N; Finelli C; Porta MD; Fenaux P; Ganser A; Guerci-Bresler A; Schmid M; Taylor K; Vassilieff D; Habr D; Domokos G; Roubert B; Rose C; Baccarani M; EPIC study investigators.
Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment
2010 Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Carla Filì; Chiara Colombi; Michele Baccarani; Giovanni Martinelli; Domenico Russo; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco
Nuclear inositide signaling in myelodysplastic syndromes.
2010 Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli AM; Cocco L
Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response
2011 C. Finelli; C. Clissa; M. Follo; A. Curti; S. Paolini; C. Papayannidis; S. Mongiorgi; S. Parisi; L. Manzoli; G. Martinelli; L. Cocco; M. Baccarani
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients
2011 Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco
Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients
2011 Matilde Y. Follo; Sara Mongiorgi; Cristina Clissa; Costanza Bosi; Michele Baccarani; Giovanni Martinelli; Patrizia Santi; Giulia Ramazzotti; Anna Maria Billi; Lucia Manzoli; Carlo Finelli; Lucio Cocco
Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study
2011 C. Fill; C. Finelli; M. Gobbi; G. Martinelli; I. Iacobucci; E. Ottaviani; L. Cocco; F. Matilde; A. Candoni; E. Simeone; M. Miglino; F. Lauria; M. Bocchia; M. Defina; C. Clissa; F. Lanza; P. Spedini; C. Skert; C. Bergonzi; M. Malagola; A. Peli; A. Turra; F. Cattina; C. Colombi; D. Russo
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasia. | MANDREOLI M; FINELLI C; LOPEZ A; ASCANI S; VIANELLI N; BACCARANI M.; SANTORO A. | 2004-01-01 | AMERICAN JOURNAL OF KIDNEY DISEASES | - | 1.01 Articolo in rivista | - |
| Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. | Follo MY; Bosi C; Finelli C; Fiume R; Faenza I; Ramazzotti G; Gaboardi GC; Manzoli L; Cocco L. | 2006-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | - | 1.01 Articolo in rivista | - |
| PI-PLCbeta1 Expression in Patients with High-Risk Myelodysplastic Syndromes Is Affected by Azacitidine Treatment. | Carlo Finelli; Matilde Y. Follo; Costanza Bosi; Sara Mongiorgi; Cristina Clissa; Giovanni Martine...lli; Michele Baccarani; Alberto M. Martelli; Lucio Cocco | 2007-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation | Follo, Matilde Y.; Mongiorgi, Sara; Bosi, Costanza; Cappellini, Alessandra; Finelli, Carlo; Chiar...ini, Francesca; Papa, Veronica; Libra, Massimo; Martinelli, Giovanni; Cocco, Lucio; Martelli, Alberto M. | 2007-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Paraplegia due to a paravertebral extramedullary haemopoiesis in a patient with polycythaemia vera. | Piccaluga PP; Finelli C; Vigna E; Agostinelli C; Bacci F; Paolini S; Papayannidis C; Laterza C; M...artinelli G; Pileri SA; Baccarani M. | 2007-01-01 | JOURNAL OF CLINICAL PATHOLOGY | - | 1.01 Articolo in rivista | - |
| PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes | Follo MY; Finelli C; Bosi C; Martinelli G; Mongiorgi S; Baccarani M; Manzoli L; Blalock WL; Marte...lli AM; Cocco L | 2008-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| PKR is activated in MDS patients and its subcellular localization depends on disease severity. | Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Martinelli G; Blalock WL; Cocco L; Martelli AM. | 2008-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Identification of Novel Cryptic Chromosomal Abnormalities in Primary Myelofibrosis by Single-Nucleotide Polymorphism Oligonucleotide Microarray. | Visani G.; Isidori A.; Sapienza MR.; Righi S.; Laginestra A.; Agostinelli C.; Sabattini E.; De Ni...ctolis M.; Valentini M.; Donati M.; Emiliani R.; Gazzola A.; Mannu C.; Rossi M.; Alesiani F.; Martinelli G.; Iacobucci I.; Paolini S.; Ascani S.; Finelli C.; Vianelli N.; Pileri SA.; Piccaluga PP. | 2009-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients. | Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele B...accarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco | 2009-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
| Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia. | Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martell...i AM; Cocco L. | 2009-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes. | 17. Voso MT; Santini V; Finelli C; Musto P; Pogliani E; Angelucci E; Fioritoni G; Alimena G; Maur...illo L; Cortelezzi A; Buccisano F; Gobbi M; Borin L; Di Tucci A; Zini G; Petti MC; Martinelli G; Fabiani E; Fazi P; Vignetti M; Piciocchi A; Liso V; Amadori S; Leone G. | 2009-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. |
Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Testoni N; Chiarini F; Ramazzotti G; Baccara...ni M; Martelli AM; Manzoli L; Martinelli G; Cocco L |
2009-01-01 | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | - | 1.01 Articolo in rivista | - |
| Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study | Carla Filì; Carlo Finelli; Marco Gobbi; Giovanni Martinelli; Ilaria Iacobucci; Emanuela Ottaviani...; Lucio Cocco; Matilde Y. Follo; Anna Candoni; Erika Simeone; Maurizio Miglino; Francesco Lauria; Monica Bocchia; Marzia Defina; Cristina Clissa; Francesco Lanza; Antonio Curti; Stefania Paolini; Pier Angelo Spedini; Cristina Skert; Cesare Bergonzi; Michele Malagola; Annalisa Peli; Alessandro Turra; Federica Cattina; Chiara Colombi; Domenico Russo | 2010-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
| Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study. | Gattermann N; Finelli C; Porta MD; Fenaux P; Ganser A; Guerci-Bresler A; Schmid M; Taylor K; Vass...ilieff D; Habr D; Domokos G; Roubert B; Rose C; Baccarani M; EPIC study investigators. | 2010-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
| Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment | Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Carla Filì; Chiara Colombi; Michele Baccarani; ...Giovanni Martinelli; Domenico Russo; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco | 2010-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
| Nuclear inositide signaling in myelodysplastic syndromes. | Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli ...AM; Cocco L | 2010-01-01 | JOURNAL OF CELLULAR BIOCHEMISTRY | - | 1.01 Articolo in rivista | - |
| Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response | C. Finelli; C. Clissa; M. Follo; A. Curti; S. Paolini; C. Papayannidis; S. Mongiorgi; S. Parisi; ...L. Manzoli; G. Martinelli; L. Cocco; M. Baccarani | 2011-01-01 | LEUKEMIA RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients | Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni... Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco | 2011-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
| Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients | Matilde Y. Follo; Sara Mongiorgi; Cristina Clissa; Costanza Bosi; Michele Baccarani; Giovanni Mar...tinelli; Patrizia Santi; Giulia Ramazzotti; Anna Maria Billi; Lucia Manzoli; Carlo Finelli; Lucio Cocco | 2011-01-01 | ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY | - | 4.01 Contributo in Atti di convegno | - |
| Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study | C. Fill; C. Finelli; M. Gobbi; G. Martinelli; I. Iacobucci; E. Ottaviani; L. Cocco; F. Matilde; A.... Candoni; E. Simeone; M. Miglino; F. Lauria; M. Bocchia; M. Defina; C. Clissa; F. Lanza; P. Spedini; C. Skert; C. Bergonzi; M. Malagola; A. Peli; A. Turra; F. Cattina; C. Colombi; D. Russo | 2011-01-01 | LEUKEMIA RESEARCH | - | 4.02 Riassunto (Abstract) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile